TherapeuticsMD, Inc. short interest in 2024
In 2024, TherapeuticsMD, Inc.'s disclosed short interest ran from 1.23% of shares outstanding on 12 Jan 2024 to 0.79% on 13 Sep 2024, a change of -0.44 percentage points. The year's high was 1.23% on 12 Jan 2024 and its low 0.29% on 14 Jun 2024, averaging 0.53% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.55 days on 13 Sep 2024. Full history: TherapeuticsMD, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.23% (12 Jan 2024)
- End of year
- 0.79% (13 Sep 2024)
- Change
- -0.44 pp
- High
- 1.23% (12 Jan 2024)
- Low
- 0.29% (14 Jun 2024)
- Average
- 0.53%
- Highest days to cover
- 8.55 (13 Sep 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 1.23% | 8.37 | |
| 31 Jan 2024 | 0.52% | 3.65 | |
| 15 Feb 2024 | 0.48% | 4.84 | |
| 29 Feb 2024 | 0.39% | 2.24 | |
| 15 Mar 2024 | 0.45% | 1.48 | |
| 28 Mar 2024 | 0.39% | 2.27 | |
| 15 Apr 2024 | 0.40% | 1.28 | 10-K filed, results (8-K) |
| 30 Apr 2024 | 0.44% | 2.70 | |
| 15 May 2024 | 0.34% | 3.15 | 10-Q filed, results (8-K) |
| 31 May 2024 | 0.32% | 2.99 | |
| 14 Jun 2024 | 0.29% | 2.78 | |
| 28 Jun 2024 | 0.46% | 2.05 | |
| 15 Jul 2024 | 0.37% | 1.76 | |
| 31 Jul 2024 | 0.36% | 5.02 | |
| 15 Aug 2024 | 0.98% | 6.50 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 0.86% | 6.01 | |
| 13 Sep 2024 | 0.79% | 8.55 |
See also: TherapeuticsMD, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.